Ervin Mazniku, MD, PhD(c)

AI platforms that absorb trial data reconciliation could compress operations toward a small, accountable team.

Investigator-initiated trials operate under the same regulatory and operational requirements as industry-sponsored studies but rely on fragmented, consumer-grade tools, creating a persistent technology gap that can impact data integrity, efficiency, and compliance.